Good questions. Clearer answers.
Explore medical weight loss, hormones, men’s health, and everyday wellbeing. Find a topic, read at your pace, and bring your questions to us.

GLP-1 Treatment and Eating Habits: What Research Can Tell Us
A careful look at a 2026 review of GLP-1 medicines, appetite, eating behavior, and energy intake—and what its scope can and cannot tell you.
Read the story
If Weight-Management Medication Stops: Ongoing Support
Questions to discuss with a licensed clinician about weight maintenance, possible weight regain, and ongoing support if you are considering stopping weight-management medication.
Read the story
Menopause Hormone Consultation: Questions to Prepare
Prepare for a menopause hormone consultation with questions about goals, personal health context, evidence, and risk discussions.
Read the story
Menopausal Hormone Therapy Label Changes: What the FDA Update Means
Learn what the FDA’s menopausal hormone therapy label update changes, what it does not establish, and what to ask a licensed clinician.
Read the story
Beyond Weight Change: Questions About New Obesity Medicines
Learn how to discuss goals beyond weight change, interpret obesity-medicine research carefully, and prepare questions for a clinical consultation.
Read the story
Testosterone After Menopause: Evidence Gaps and Questions
Explore questions about testosterone use after menopause, evidence uncertainties, and how to discuss options with a licensed clinician.
Read the story
2026: Questions About Lifestyle Support and Weight Medication
Prepare for a weight-management consultation with questions about goals, lifestyle support, medication discussions, and follow-up.
Read the story
Supplement Research and Weight Management: What Can a Study Show?
Learn how to evaluate supplement research and weight-loss claims, what a study of another health measure can establish, and what Atlanta adults can ask a clinician.
Read the story
Sarcopenic Obesity During Menopause: What a Cohort Study Can—and Cannot—Tell You
Learn what sarcopenic obesity means, what a Korean cohort observed across menopause stages, and why observational findings cannot predict an individual’s body composition or prove cause.
Read the story
What Early Oral Semaglutide Uptake Data Can—and Can’t—Tell Atlanta Adults
Learn what medication uptake data can and cannot establish about oral semaglutide and obesity, and which questions Atlanta adults can bring to a physician discussion.
Read the story
GLP‑1s and Knee Osteoarthritis: How 2026 Evidence Can Inform Atlanta Care Conversations
How 2026 evidence and ACR’s conditional update on GLP‑1s relate to knee osteoarthritis and physician‑supervised weight management in Atlanta. Safety, expectations, and visit questions—without assuming an individual outcome.
Read the story
Low T Evaluation in Atlanta: When Calculated Free Testosterone Matters in Obesity or Diabetes
In Atlanta, men with obesity or diabetes may benefit from calculated free testosterone in low T evaluations because SHBG can alter total levels. Learn why morning, repeat testing and assay quality matter, and which clinic-visit questions to ask without assuming outcomes.
Read the story